Under Nevada law, because the Reverse Split was approved by the shareholders of the Company on February 14, 2025, and in accordance with NRS Section 78.2055, the Company may effect the Reverse Split ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, ...

Robert L. Reffkin, the Chairman and CEO of Compass , Inc. (NYSE:COMP), a $4.2 billion real estate technology company whose stock has surged nearly 100% over the past year, recently sold a significant ...

AGNC Investment Corp. Dep. Pfd. (Rep. 6.875% Cum. Redeem. Pfd. Series D 0.20% AGNC Investment Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Series C) 0.31% AGNC Investment Corp ...

We read all day so you don't have to. Sign up for CNN Business' newsletter for the top stories you need to know.

Stock markets at close: Nifty Smallcap 100 index enters bear phase; tanks 22% from peak ...